Optimization of a 40-mer Antimyelin DNA Aptamer Identifies a 20-mer with Enhanced Properties for Potential Multiple Sclerosis Therapy

Brandon Wilbanks, John Smestad, Robin M. Heider, Arthur E. Warrington, Moses Rodriguez, L. James Maher

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Optimization of a 40-mer Antimyelin DNA Aptamer Identifies a 20-mer with Enhanced Properties for Potential Multiple Sclerosis Therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds